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A b s t r a c t  
Bioactive heterocyclic rings 1,3,4-oxadiazole and 1,3,5-triazine are fused with expectation of 
enhanced biological activity of the newly synthesized compounds. Hence Synthesized fused 
heterocyclic compounds as a substituted aryl- 1,3,4-oxadiazolo-[3,2-a]-1,3,5-triazine derivatives 
The structures of all the compounds were confirmed by physical and spectral analysis. The newly 
synthesized compounds were evaluated for antimicrobial activity against a variety of bacterial strains 
and fungal strains. Some of these compounds have shown significant antibacterial and antifungal 
activity. 
Keywords: 1,3,5-triazine, 1,3,4-Oxadiazole, 1,3,4-oxadiazolo-[3,2-a]-1,3,5-triazine, SchiffÊs base, 
Antimicrobial activity  
Introduction 
1,3,5-triazines are amongst the oldest known organic molecules; 
originally they were called the symmetric triazines usually 
abbreviated as S- or Syn-triazines. Some of the substituted 1,3,5-s-
triazine have reported to possess interested biological activities. A 
wide range of 1,3,5-triazines exhibit selective herbicidal properties, 
Simazine and atrazines are the organic compounds containing s-
triazine skeleton are most important herbicides.[1] Triazines 
derivative Altretamine and  triethylene melamine (TEM) shown 
activity against leukemia. Compounds contain 1,3,5-triazine as a 
lead moiety possessing a wide spectrum of biological activities 
such as anti-cancer[2-6], antiviral [7], bactericidal [8-14], 
fungicidal[15-17], antimalarial agents[18-20] and anti-
tuberculosis[21]. In addition, the interest in 1,3,4-oxadiazole also 
one of important heterocyclic compound show significant biological 
activity such as antibacterial and fungicidal.[22-25]  
In view of these observations and in continuation of our work 
synthesized novel compounds 1,3,4-oxadiazolo[3,2-a]-s-triazine 
derivatives (3a-3n and 4a-4n) by bridging of both bioactive 
heterocyclic rings as fused heterocycles with expectation of 
enhanced biological activity of the molecule. Hence we have 
carried out synthesis, characterization and antimicrobial activities 
of title compounds which are new and are not reported so far 
elsewhere. 
Required semicarbazones were prepared by using the reported 
method as a reaction between aldehyde and semicarbazide 
(VogelÊs,1996). Starting compound 2-amino-5-phenyl-1,3,4-
oxadiazole were synthesized by using Semicarbazone (0.01 M) 
and sodium acetate (0.02 M) were dissolved in 30ă40 ml of glacial 
acetic acid taken in a round-bottomed flask equipped with a 
separating funnel for the addition of bromine. Bromine (0.7 ml in 
5ml glacial acetic acid) was added slowly to it, while stirring 
magnetically. After half an hour stirring, the solution was poured on 
crushed ice. The resulting solid was separated, dried and 
recrystallized from ethanol (VogelÊs, 1996). Respective SchiffÊs 
base were synthesized reaction between 2-amino-5-phenyl-1,3,4-
oxadiazole and aromatic aldehyde.26 The present study report the 
synthesis of  various substituted aryl-1,3,4-oxadiazole-[3,2-a]-1,3,5-
triazine derivatives (Scheme-1 and Scheme-2). The compounds 
synthesized were characterized by using their spectral data. (IR, 
NMR and Mass) All synthesized molecules are evaluated to in-vitro 
antimicrobial activities against various microbial strains. 
Experimental Section  
Melting points were determined in open capillary tubes and were 
found uncorrected. The temperatures were expressed in ÀC. TLC 
was performed to monitor the progress of reactions. All compounds 
were purified by recrystallization with suitable organic solvents. The 
Purity of all the compounds was checked by thin layer 
chromatography (TLC) on Precoated silica gel-G. Iodine chamber 
and UV lamp were used for the visualization of TLC spots. 
All the Fourier transform infra red (FTIR) spectra were recorded in 
KBr pellets on a Perkin Elmer spectrometer. The 1H-NMR spectra 
were taken on Bruker Avance-400 MHz NMR spectrometer. 
Chemical shifts are expressed in parts per million relative to 
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tetramethylsilane (TMS) as an internal standard. Mass spectra 
were recorded on LC-MSD-Tranp-SL2010A Shimadzu.  
Chemistry 
Synthesis of SchiffÊs base: A solution of 2-amino-5-phenyl-1,3,4-
oxadiazole (0.01 M) was prepared in 30 ml alcohol in a round-
bottomed flask. Benzaldehyde (0.01 M) then added to it. The 
mixture was refluxed for 5ă6 h. The volume of alcohol was reduced 
to half by distillation under reduced pressure. The resulting solution 
was poured on crushed ice. The precipitate which got separated 
was dried and recrystallized from alcohol. (compound-1) 
Synthesis of 7-substituted aryl-2,6-diphenyl-5-thioxo-[1,3,4]-
oxadiazolo-[3,2-a][1,3,5]-triazine : A mixture of SchiffÊs base 
(compound-1) (0.01 mol) and phenylisothiocynate (0.01 mol) was  
refluxed for 7 hr in dry toluene. The solvent was distillation under 
reduced pressure. The residue obtained was filter, wash a small 
amount of ethanol followed by water and purified by recrystallized 
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thione(3a):    
M.P.-185oC, IR(KBr): 3124.47(=C-H str.), 2948.96(C- H str.), 
1446.51(C=C str.), 1610.45(C=N str.), 1076.21(C-O-C str.), 
1278.72(N-N=C str.) and 1174.57(C=S str.). 1H-NMR(DMSO,            





M.P.-265oC, IR(KBr): 3467.77(O-H str.), 3103.25(=C-H str.), 
2943.17(C- H str.), 1448.44       (C=C str.), 1696.95(C=N str.), 
1018.34(C-O-C str.), 1222.79(N-N=C str.) and  1151.42                    
(C=S str.). 1H-NMR(DMSO,Ē ppm): 5.47(s, 1H, OH), 3.52(s, 1H, N-




M.P.-254oC, IR(KBr): 3317.34(O-H str.), 2952.81(=C-H str.), 
2891.10(C- H str.), 1442.66     (C=C str.), 1647.10(C=N str.), 
1107.06(C-O-C str.), 1245.93(N-N=C str.)  and 1168.78        (C=S 




M.P.-228oC, IR(KBr): 3427.27(O-H str.),  2975.96(=C-H str.), 
2876.74(C- H str.), 1465.80   (C=C str.), 1604.66(C=N str.), 




a][1,3,5]triazine-5-thione(3e):   
M.P.-220oC, IR(KBr): 3132.18(=C-H str.), 2950.89(C-H str.), 
1446.51(C=C str.), 1610.45(C=N str.), 1074.57(C-O-C str.), 
1278.72(N-N=C str.), 1571.88(C-NO2 str.) and  1188.07(C=S str.). 
1H-NMR (DMSO,Ē ppm): 3.9(s, 1H, N-CH-N), 7.19-7.83(m, 14H, Ar-




M.P.- 195oC, IR(KBr):  2954.74(=C-H str.), 2912.31(C- H str.), 
1452.30(C=C str.), 1618.17 (C=N str.), 1058.92(C-O-C str.), 
1255.57(N-N=C str.), 1348.05(C-NO2 str.) and  1207.36     (C=S 
str.). MS: m/z-429.2 
2,6-diphenyl-7-(4-nitrophenyl)-[1,3,4]oxadiazolo[3,2-
a][1,3,5]triazine-5-thione(3g): 
M.P.- 234oC, IR(KBr):  2948.42(C- H str.), 1479.30(C=C str.), 
1639.38(C=N str.), 1051.31     (C-O-C str.), 1253.64(N-N=C str.), 




M.P.-247oC, IR(KBr): 3052.11(=C-H str.), 2941.24(C- H str.), 
1458.08(C=C str.), 1664.45  (C=N str.), 1070.42(C-O-C str.), 
1232.43(N-N=C str.), 1151.42(C=S str.) and 775.33(C-Cl str.). 1H-
NMR(DMSO,Ē ppm): 4.13(s, 1H, N-CH-N), 7.15 ă 7.97(m, 14H, Ar-
H), MS: m/z-418.1 
 
2,6-diphenyl-7-(4-chlorophenyl)-[1,3,4]oxadiazolo[3,2-
a][1,3,5]triazine-5-thione(3i):   
M.P.- 174oC, IR(KBr): 3015.70(=C-H str.), 2955.34 (C- H str.), 
1454.23 (C=C str.), 1674.10 (C=N str.), 1151.42(C-O-C str.), 




[1,3,4]oxadiazolo[3,2-a][1,3,5]triazine-5-thione(3j):    
M.P.- 217oC, IR(KBr):2991.39(=C-H str.), 2839.02(C- H str.), 
1433.01(C=C str.), 1654.81(C=N str.), 1074.28(C-O-C str.), 
1232.43(N-N=C str.) and 1201.57(C=S str.). 1H-NMR(DMSO,Ē 
ppm): 3.96(s, 1H, N-CH-N), 2.88(s, 6H, 2CH3), 7.24 ă 7.98(m, 14H, 
Ar-H), MS: m/z-427.2 
 
2,6-diphenyl-7-(3,4,5-trimethoxyphenyl)-
[1,3,4]oxadiazolo[3,2-a][1,3,5]triazine-5-thione(3k):    
M.P.- 284oC, IR(KBr):  3001.03(=C-H str.), 2839.02(C- H str.), 
1442.66(C=C str.), 1622.02 (C=N str.), 1016.42(C-O-C str.), 
1238.21(N-N=C str.) and 1188.07(C=S str.). MS: m/z-474.5 
2,6-diphenyl-7-(4-methoxy phenyl)-
[1,3,4]oxadiazolo[3,2-a][1,3,5]triazine-5-thione(3l):              
M.P.- 158oC, (KBr): 2985.67(=C-H str.), 2870.95(C-H str.), 
1471.59(C=C str.), 1596.95(C=N str.), 1105.14(C-O-C str.), 




M.P.- 205oC, IR(KBr): 3355.91(O-H str.), 2977.89(=C-H str.), 
2837.09(C-H str.), 1448.94(C=C str.),  1693.38(C=N str.), 
1054.99(C-O-C str.), 1276.79(N-N=C str.) and 1203.50(C=S str.).   
MS: m/z-430.2 
2,6-diphenyl-7-(2,5-dichlorophenyl)-
[1,3,4]oxadiazolo[3,2-a][1,3,5]triazine-5-thione(3n):           
M.P.-189oC, IR(KBr):  2998.25(=C-H str.), 2888.67(C-H str.), 
1433.01(C=C str.), 1625.88(C=N str.), 1008.70(C-O-C str.), 
Basedia et al. International Journal of Drug Delivery 5 (4) 379-388 [2013] 
 
PAGE | 382 |
 
 
1274.86(N-N=C str.), 1147.57(C=S str.) and 746.40(C-Cl str.).      
MS: m/z-452.6 
Synthesis of 7-substituted aryl-2-phenyl-5-thioxo-[1,3,4]-
oxadiazolo-[3,2-a][1,3,5]-triazine:  
A mixture of SchiffÊs base (compound-1) (0.01 mol) and ammonium 
thiocyanate (0.01 mol) were dissolved in dioxin (20 ml) by slow 
warming and shaking. The reaction mixture was stirred for 30 min 
at room temperature and subsequently refluxed for 5 hr. The 
solvent was distillation under reduced pressure. The residue 
obtained was wash with water, dried and recrystallized from 
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M.P.-135oC, IR(KBr): 3211.72(N-H str.), 3110.95(=C-H str.), 
2938.47(C- H str.), 1452.39    (C=C str.), 1597.85(C=N str.), 
1069.19(C-O-C str.), 1243.75(N-N=C str.) and 1189.86(C=S str). 
1H-NMR(DMSO,Ē ppm): 2.14(s, 1H, NH), 3.81(s, 1H, CH), 7.14ă 
7.81(m, 10H, Ar-H),         MS: m/z-308.2 
 
7-(2-hydroxyphenyl)-2-phenyl-[1,3,4]oxadiazolo[3,2-
a][1,3,5]triazine-5-thione(4b):   
M.P.-152oC, IR(KBr): 3410.22(O-H str.),  3038.05(N-H str.), 
2903.59(C- H str.), 1445.26(C=C str.), 1659.13(C=N str.), 
1075.56(C-O-C str.), 1259.94(N-N=C str.) and 1202.31(C=S str).      
1H-NMR(DMSO,Ē ppm): 2.57(s, 1H, NH), 5.37(s, 1H, OH), 3.77(s, 
1H, CH), 6.96-7.79(m, 9H, Ar-H), MS: m/z-324.4 
 
7-(3-hydroxyphenyl)-2-phenyl-[1,3,4]oxadiazolo[3,2-
a][1,3,5]triazine-5-thione(4c):   
M.P.-169oC, IR(KBr): 3423.00(O-H str.), 3158.93(=C-H str.),  
2933.34(C- H str.), 1477.37   (C=C str.), 1670.41(C=N str.), 
1133.34(C-O-C str.), 1241.42(N-N=C str.) and 1153.82(C=S str). 
MS: m/z-324.1 
7-(4-hydroxyphenyl)-2-phenyl-[1,3,4]oxadiazolo[3,2-
a][1,3,5]triazine-5-thione(4d):    
M.P.-174oC , IR(KBr):  3313.59(O-H str.), 3062.14(=C-H str.),  
2916.06(C- H str.), 1433.91 (C=C str.), 1676.12(C=N str.), 




a][1,3,5]triazine-5-thione(4e):    
M.P.-187oC, IR(KBr): 3332.47(N-H str.), 3092.27(=C-H str.), 
2849.06(C- H str.), 1345.43(C=Cstr.), 1667.22(C=N str.), 
1097.62(C-O-C str.), 1265.91(N-N=Cstr.), 1533.45(C-NO2 str.) and 
1103.36(C=S str).1H-NMR(DMSO,Ē ppm): 2.24(s, 1H, NH), 3.48       
(s, 1H, CH), 6.81 ă 7.94(m, 9H, Ar-H), MS: m/z-353.4 
7-(3-nitrophenyl)-2-phenyl-[1,3,4]oxadiazolo[3,2-
a][1,3,5]triazine-5-thione(4f):      
M.P.-195oC, IR(KBr):  3407.07(N-H str.), 3108.09(=C-H str.), 
2905.12(C- H str.), 1458.52   (C=C str.), 1596.15(C=N str.), 
1093.60(C-O-C str.), 1250.04(N-N=C str.), 1546.13(C-NO2 str.) and 
1208.08(C=S str).MS: m/z-353.2 
7-(4-nitrophenyl)-2-phenyl-[1,3,4]oxadiazolo[3,2-
a][1,3,5]triazine-5-thione(4g):  
M.P.-207oC, IR(KBr): 3401.74(N-H str.),  3030.48(C- H str.), 
1490.09(C=C str.), 1643.26    (C=N str.), 1071.10(C-O-C str.), 
1238.36(N-N=C str.), 1596.02(C-NO2 str.) and 1177.93      (C=S 




M.P.-163oC, IR(KBr):  3311.64(N-H str.),  2917.71(C- H str.), 
1480.82(C=C str.), 1688.48(C=N str.), 1109.57(C-O-C str.), 
1258.80(N-N=C str.), 769.42(C-Cl str.) and 1167.77(C=S str).         
1H-NMR(DMSO, Ē ppm): 2.09(s, 1H, NH), 3.53(s, 1H, CH), 7.10 ă




M.P.-186oC, IR(KBr):  3416.90(N-H str.), 3136.90(C- H str.), 
1445.38(C=C str.), 1661.74(C=N str.), 1064.01(C-O-C str.), 
1265.91(N-N=C str.), 727.22(C-Cl str.) and 1233.28(C=S str).       
MS: m/z-342.3 
7-(4-dimethylaminophenyl)-2-phenyl-
[1,3,4]oxadiazolo[3,2-a][1,3,5]triazine-5-thione(4j):          
M.P.-180oC, IR(KBr):  3456.23(N-H str.),  2921.10(=C-H str.), 
2850.09(C- H str.), 1466.95 (C=C str.), 1672.31(C=N str.), 
1104.83(C-O-C str.), 1381.41(N-N=C str.) and 1172.13(C=S str). 
1H-NMR(DMSO, Ē ppm): 2.25(s, 1H, NH), 2.80(s , 6H, 2CH3), 6.49-
7.43(m, 9H, Ar-H),       MS: m/z-351.1 
7-(3,4,5-trimethoxyphenyl)-2-phenyl-
[1,3,4]oxadiazolo[3,2-a][1,3,5]triazine-5-thione(4k):          
M.P.-225oC, IR(KBr):  3303.83(N-H str.), 2917.74(C- H str.), 
1454.73(C=C str.), 1697.98(C=N str.), 1093.52(C-O-C str.), 
1242.16(N-N=C str.) and 1172.00(C=S str). MS: m/z-398.2 
7-(4-methoxyphenyl)-2-phenyl-[1,3,4]oxadiazolo[3,2-
a][1,3,5]triazine-5-thione(4l):   
M.P.-160oC, IR(KBr): 3250.67(N-H str.), 2917.00(C- H str.), 
1452.35(C=C str.), 1692.50     (C=N str.), 1043.23(C-O-C str.), 
1291.18(N-N=C str.) and 1243.33(C=S str) MS: m/z-338.1 
7-(4-hydroxy-3-methoxyphenyl)-2-diphenyl-
[1,3,4]oxadiazolo[3,2-a][1,3,5]triazine-5-thione(4m): 
M.P.-214oC, IR(KBr):  3371.72(O-H str.), 3312.73(N-H str.), 
3078.85(C- H str.), 1505.37(C=C str.), 1689.84(C=N str.), 
1038.12(C-O-C str.), 1270.29(N-N=C str.) and 1158.14 (C=S str).  
MS: m/z-354.2 
7-(2,5-dichlorophenyl)-2-phenyl-[1,3,4]oxadiazolo[3,2-
a][1,3,5]triazine-5-thione(4n):      
M.P.-220oC, IR(KBr):  3366.22(N-H str.), 3113.59(=C-H str.), 
2936.90(C-H str.), 1550.28(C=C str.), 1647.93(C=N str.), 
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1047.94(C-O-C str.), 1237.90(N-N=C str.), 1127.64(C=S str) and 
799.34(C-Cl str.), MS: m/z-377.3 
Antimicrobial activity  
All the newly synthesized compounds (3a-3n) and (4a-4n) were 
evaluated for in vitro Antimicrobial activity against gram positive 
and gram negative bacterial strains such Escherichia coli (Gram - 
ve), Klebsiella pneumonia (Gram ă ve), Staphylococcus aureus 
(Gram +ve), Bacillus subtilis (Gram +ve) and fungal strains 
Aspergillus niger at three different concentration 100 μg/ml, 200 
μg/ml and 300 μg/ml by Cup-Plate method and nutrient agar was 
employed as culture media(beef extract 3 gm, Agar 15 g, Peptic 
Digest of Animal Tissue 5 g, sodium chloride 5 g and distilled 
water-q.s. to 1,000 ml) was employed as culture media for 
antimicrobial activity. The sterilization of the nutrient broth, culture 
tubes, pipette and other glassware was done by autoclaving. For 
antibacterial studies, incubation was carried out at 37ĈC for 24 hr 
and for antifungal studies, incubation was carried out at 25μ2Àc for 
72 hr. The zone of inhibition was measured in mm.[29-30] The 
activity was compared with known antibiotic Ciprofloxacin and 
Ketoconazole as standards for antibacterial and antifungal studies 
respectively and zone of inhibition were measured for all 
synthesized compounds.  
Results and discussion 
The present study report the synthesis of novel  substituted aryl- 
1,3,4-oxadiazolo-[3,2-a]-1,3,5-triazine derivatives. The first step 
involve synthesized the SchiffÊs base as reaction between 2-amino-
5-phenyl-1,3,4-oxadiazole and aromatic aldehyde.  
In Step -2: synthesized 7-substituted aryl -2,6-diphenyl-5-thioxo-
[1,3,4]-oxadiazolo-[3,2-a] [1,3,5]-triazine (Scheme-1) and 7-
substituted aryl-2-phenyl-5-thioxo-[1,3,4]-oxadiazolo-[3,2-a][1,3,5]-
triazine (Scheme-2). Series of compounds 3a-3n and 4a-4n 
synthesized and reported. 
The synthesized compounds were recrystallized and identified by 
TLC. The melting point were found uncorrected. The difference in 
the Rf  value and melting point show the change in the structure 
between the molecules. All Physical data of the compounds are 
recorded in table-01 and table-02  
IR Spectra were recorded in KBr pellets on Perkin Elmer FT-IR 
instrument. All the compounds show aromatic C-H stretching 
between 3124.2 to 2952.8 cm-1, aliphatic C-H stretching between  
2948.9 to 2876.7 cm-1, C=N in ring between 1647.1 -1597.8 cm-1 
and C-O-C stretching between 1075.5- 1018.3 cm-1 presence of 
cyclic ring system in [1,3,4] oxadiazoline. All the compounds show 
C=C stretching vibration at 1479.3-1452.3 cm-1  and C=S stretching 
vibration at 1189.11-1151.4 cm-1 . Compound 3a-3n show 
stretching vibration between 3467.7 to 3317.3 the presence of 0-H 
group. Compounds 4a-4n show the presence of N-H stretching 
vibration in amine between 3432.1 to 3410.2 cm-1,                                                
In compound 3j and 4j show C-H str. due to CH3 at 2839 and 
2917cm-1. Compounds 3e, 3f, 3g and Compounds 4e, 4f, 4g show 
characteristic C-NO2 stretching vibration between 1571.8 ă 1560.3 
cm-1  and 1596 ă 1533.4 cm-1  respectively may be due to nitro 
group in compounds. Compound 3h, 3i, 3n  and  4h, 4i, 4n  show 
C-Cl stretching  vibration at 775.3 ă 742.5 cm-1  and 769.4 - 727 
cm-1  presence of chlorine substitution in respective compounds . 
1NMR was recorded on Bruker Avance-400 MHz 
NMR spectrometer chemical shift was measured at part per million 
downfield from tetra methyl silane. Compounds 4a-4n show sharp 
singlet near Ē 2.09 to 2.57 might be due to NH proton. All 
compounds show multiple between Ē 7.15 to 7.94 showed the 
presence of aromatic proton (Ar-H). The singlet formed between Ē 
5.37 to 5.37 might be due to presence of OH in compounds 3b and 
4b respectively. Compound 3j and 4j show sharp singlet at Ē 2.88 
and 2.80 respectively due to presence of CH3 in dimethylamine. All 
compounds show sharp singlet near Ē 3.48 to 3.93 might be due to 
CH proton in C-7 position in ring. 
Mass spectra were recorded on LC-MSD-Trap-SL which show 
characteristic molecular ion and base peak and further confirmed 
the compounds. 
Antimicrobial activity of synthesized compounds was evaluated by 
cup-plate method. All the synthesized compounds show a 
moderate biological activity. Compound 3c, 3h, 3m and 4c, 4k, 4m 
showed very good activities against the entire test microorganism. 
Increase the antibacterial activity of compounds due to presence of  
hydroxyl substitution in the m-position (3c and 4c) and compounds 
3m, 4m show higher antibacterial activity against all the test 
microorganisms due to 4-hydroxy-3-methoxy substitution. 2-Cholro 
and 3,4,5-trimethoxy substituted group also show good 
antibacterial agent (3h and 4k). All synthesized compounds are 
active against gram positive and negative microorganism. 
Compound 3c, 3h, 3m and 4c, 4k, 4m has highest antibacterial 
activity against all the test microorganisms. 
All synthesized compounds show antifungal against fungal strains 
Aspergillus niger. The compound 3c, 3k, 3f, 4a and 4c are most 
active and  show better significant antifungal activity. Antimicrobial 
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1. 3a C22H16N4OS 384.45 185oC 0.71 77 Light Yellow 
2. 3b C22H16N4O2S   400.45 265oC 0.80 69 Brown 
3. 3c C22H16N4O2S   400.45 254oC 0.69 81 Yellow 
4. 3d C22H16N4O2S   400.45 228oC 0.78 78 Yellow 
5. 3e C22H15N5O3S 429.45 220oC 0.73   65 Brown 
6. 3f C22H15N5O3S 429.45 195oC 0.77 80 Yellow 
7. 3g C22H15N5O3S 429.45 234oC 0.83 82 Light brown 
8. 3h C22H15ClN4OS 418.89 247oC 0.66   60 White 
9. 3i C22H15ClN4OS 418.89 174oC 0.74 80 Yellow 
10. 3j C24H21N5OS 427.52 217oC 0.82 73 Dark brown 
11. 3k C25H22N4O4S 474.53 284oC 0.63 78 Yellow 
12. 3l C23H18N4O2S 414.47 158oC  0.75 70 Light green 
13. 3m C23H18N4O3S 430.47 205oC 0.60 75 White 
14. 3n C22H14Cl2N4OS 452.34 189oC 0.64 83 Yellow 
 
 
















1. 4a C16H12N4OS 308.36 135oC 0.76 70 Yellow 
2. 4b C16H12N4O2S 324.36 152oC 0.72 82 Light brown 
3. 4c C16H12N4O2S 324.36 169oC 0.59 86 White 
4. 4d C16H12N4O2S 324.36 174oC 0.81 63 Yellow 
5. 4e C16H11N5O3S 353.36 187oC 0.66 74 Dark brown 
6. 4f C16H11N5O3S 353.36 195oC 0.62 85 Light Yellow 
7. 4g C16H11N5O3S 353.36 207oC 0.73 65 White 
 8. 4h C16H11ClN4OS 342.80 163oC 0.76   68 Light Yellow 
9. 4i C16H11ClN4OS 342.80 186oC 0.66 72 Light brown 
10. 4j C18H17N5OS 351.43 180oC 0.74 69 White 
11. 4k C19H18N4O4S 398.44 225oC 0.71 78 Yellow 
12. 4l C17H14N4O2S 338.38 160oC 0.65 73 Yellow 
13. 4m C17H14N4O3S 354.38 214oC 0.77 80 Light brown 
14. 4n C16H10Cl2N4OS 377.25   220oC 0.64 69 White 
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Diameter of Zone of Inhibition in mm 

























3a 12 13 15   12 13 15 12 13 15 11 13 15 
3b 13 15 17 13 15 17 13 15 17 12 14 15 
3c 14 16 19 16 18 20 15 17 19 13 15 17 
3d 13 14 15 12 13 15 12 14 15 12 14 15 
3e 10 12 13 13 15 17 10 12 14 10 12 14 
3f 11 13 15 13 15 17 13 14 15 11 12 13 
3g 13 15 17 11 13 15 11 13 15 11 13 15 
3h 14 15 17 14 16 18 14 16 18 13 15 18 
3i 11 13 15 13 15 17 13 15 17 13 14 15 
3j 12 13 15 13 14 16 10 13 15 12 13 15 
3k 13 15 17   12 13 15 11 13 15 10 11 13 
3l 13 14 16 13 15 17 13 15 17 12 13 14 
3m 15 17 19 15 17 20 14 17 19 13 15 17 
3n 13 15 17 13 15 17 13 14 16 12 13 15 
Std 
(10øg/ml) 
22 22 22 23 23 23  21  21 21 20  20 20 
 
  




Diameter of Zone of Inhibition in mm 

























4a 12 14 16 12 14 16 12 14 16 11 13 15 
4b 12 14 17 13 15 17 12 13 14 12 14 16 
4c 14 16 18 16 17 19 14 16 18 14 16 18 
4d 12 14 16 12 14 16 13 14 15 13 14 16 
4e 13 15 17 12 13 15 12 13 14 12 13 14 
4f 12 14 16 11 13 15 11 13 15 12 14 16 
4g 13 14 16 12 14 16 12 14 16 11 13 15 
4h 13 15 17 14 15 17 13 14 15 13 15 16 
4i 12 13 15 14 15 17 12 14 16 12 13 14 
4j 13 15 17 11 13 15 13 15 17 12 14 16 
4k 15 17 19 15 17 19 15 17 19 14 15 17 
4l 12 13 15 12 14 16 13 14 15 12 13 14 
4m 14 16 18 16 17 20 14 16 18 14 16 18 
4n 12 14 16 13 14 15 13 15 17 11 13 15 
Std 
(10øg/ml) 
22 22 22 23 23 23 21   21   21 20 20 20 
Basedia et al. International Journal of Drug Delivery 5 (4) 379-388 [2013] 
 
PAGE | 387 |
 
 





































   
100 12 14 15 12 13 16 11 10 12 14 16 12 14 12 24 
 
200 14 16 18 13 15 18 13 12 14 15 18 14 15 15 24 
 






































100 16 12 16 13 12 13 12 13 12 13 12 14 12 13 24 
 
200 18 14 19 15 13 15 14 14 14 15 14 16 13 14 24 
 
300 20 16 21 16 16 17 15 15 16 18 15 18 16 15 24 
 
Conclusion  
A series of novel fused heterocyclic compounds 1,3,4-oxadiazolo-
[3,2-a]-1,3,5-triazine derivatives  has been successfully 
synthesized by bridging between 1,3,5-triazine nucleus which is 
one of the active lead present in many standard drugs and  
bioactive heterocyclic rings 1,3,4-oxadiazole. Hence, it is 
concluded that  1,3,4-oxadiazolo-[3,2-a]-1,3,5-triazine derivatives  
more active against all representative panel of bacterial and fungal 
strains and thus, there is enough scope for further study in 
developing such compounds as a good bioactive molecules.  
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